Monoclonal Antibody Therapy in Parkinson’s Disease — The End?
Alan Whone
Abstract
[No abstract]<br/>
Topics & Concepts
MedicineNeuroprotectionDiseaseImmunotherapyParkinson's diseaseClinical trialDopaminergicMonoclonal antibodyAntibody therapyMonoclonal antibody therapyIntensive care medicineNeuroscienceImmunologyAntibodyPathologyPharmacologyDopamineInternal medicineImmune systemBiologyParkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsNuclear Receptors and Signaling